000 | 01199 a2200361 4500 | ||
---|---|---|---|
005 | 20250513173055.0 | ||
264 | 0 | _c19920827 | |
008 | 199208s 0 0 eng d | ||
022 | _a0267-6591 | ||
024 | 7 |
_a10.1177/026765919000500103 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTamari, Y | |
245 | 0 | 0 |
_aCurrent priming solutions for cardiopulmonary bypass contain a potent coronary vasodilator. _h[electronic resource] |
260 |
_bPerfusion _c1990 |
||
300 |
_a9-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcetates _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCardioplegic Solutions _xchemistry |
650 | 0 | 4 | _aCardiopulmonary Bypass |
650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 | _aOxygen Consumption |
650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
650 | 0 | 4 | _aVasodilation |
700 | 1 | _aTortolani, J A | |
700 | 1 | _aMaguine, M | |
700 | 1 | _aCzegledy, F | |
773 | 0 |
_tPerfusion _gvol. 5 _gno. 1 _gp. 9-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/026765919000500103 _zAvailable from publisher's website |
999 |
_c10109013 _d10109013 |